Eikon Therapeutics Inc. Common Stock (EIKN)
Stock · NASDAQ · Health Care
$10.98as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$9.52
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
About EIKN
Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers a…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 384
- Website
- eikontx.com
Fundamentals
- 1-day range
- $9.7$11.26
- Market cap
- $498.62M
- P/E (trailing)
- —
- P/E (forward)
- -1.75
- EPS (trailing)
- $-5.95
- Dividend yield
- —
- Beta
- —
- Avg. volume
- 379.3K
52-week range
$7.9$17.4
Next earnings: August 13, 2026 · EPS estimate $-1.46
Forecasts
4 analyst ratings
Buy 83%
Hold 0%
Sell 17%
1-year price forecast
High
$32
+191.4%
Median
$30.5
+177.8%
Low
$26
+136.8%
Eikon Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- EIKNEikon Therapeutics Inc. Common Stock$10.98▼ 4.69%Market cap $498.62MP/E —$7.9$17.4
- PROKProKidney Corp. Class A Ordinary Shares$1.84▲ 1.10%Market cap $495.38MP/E —$1.3$3.48
- VALNValneva SE American Depositary Shares$6.43▼ 2.13%Market cap $491.51MP/E —$2.03$5.34
- KYTXKyverna Therapeutics Inc. Common Stock$8.36▼ 3.24%Market cap $471.16MP/E —$3.55$13.67
- DNAGinkgo Bioworks Holdings Inc. Class A Common Stock$6.98▼ 3.93%Market cap $528.15MP/E —$5.37$17.58
- AUTLAutolus Therapeutics plc American Depositary Share$2.34▼ 1.06%Market cap $532.31MP/E —$1.18$2.58
- PRMEPrime Medicine Inc. Common Stock$3.62▼ 0.69%Market cap $532.82MP/E —$2.67$6.94
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| EIKN Eikon Therapeutics Inc. Common Stock | $498.62M | — | $10.98 | ▼ 4.69% | $7.9$17.4 |
| PROK ProKidney Corp. Class A Ordinary Shares | $495.38M | — | $1.84 | ▲ 1.10% | $1.3$3.48 |
| VALN Valneva SE American Depositary Shares | $491.51M | — | $6.43 | ▼ 2.13% | $2.03$5.34 |
| KYTX Kyverna Therapeutics Inc. Common Stock | $471.16M | — | $8.36 | ▼ 3.24% | $3.55$13.67 |
| DNA Ginkgo Bioworks Holdings Inc. Class A Common Stock | $528.15M | — | $6.98 | ▼ 3.93% | $5.37$17.58 |
| AUTL Autolus Therapeutics plc American Depositary Share | $532.31M | — | $2.34 | ▼ 1.06% | $1.18$2.58 |
| PRME Prime Medicine Inc. Common Stock | $532.82M | — | $3.62 | ▼ 0.69% | $2.67$6.94 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →Acquired
675.3K
Disposed
0
- Michael A. Klobuchar · March 2, 2026 · Grant87.2K
- Thorner Benjamin Bruno · March 2, 2026 · Grant67.0K
- Bowie Alfred Lloyd Jr. · March 2, 2026 · Grant67.0K
- Robert Luther Huffines · March 2, 2026 · Grant25.9K
- Roy D. Baynes · March 2, 2026 · Grant134.1K
- Roger M. Perlmutter · March 2, 2026 · Grant268.2K
- Kenneth C. Frazier · March 2, 2026 · Grant25.9K
Institutional Ownership
March 31, 2026
- Total shares held
- 23.58M
- Total value held
- $226.27M
- Institutional holders
- 48
Top holders this quarter
- Unknown3.84M
- Unknown3.32M
- Unknown1.94M
- Unknown1.67M
- Unknown1.32M
- Unknown1.22M
- Unknown1.14M
- Unknown1.02M
- Unknown975.8K
- Unknown969.4K
See the full, filterable feed with live charts on the MarketWall dashboard.